[1] Kumar A, Li Y, Patil S, et al.A haplotype of the angiotensionogene is associated with hypertension in African Americans[J]. Clin Exp Pharmacol Physiol, 2005, 32(5-6):495-502. [2] Yang S, Smit AF, Schwartz S, et al.Patterns of insertions and their covariation with substitutionsin the rat, mouse, and human genomes[J]. Genome Res, 2004, 14:517-527. [3] Hammer RE, Maika SD, Richardson JA, et al.Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders[J]. Cell, 1990, 63(5):1099-1112. [4] Alam M, Mayerhofer A, Schmidt WJ.The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA[J]. Behav Brain Res, 2004, 151(1-2):117-124. [5] Lo Bianco C, Schneider BL, Bauer M, et al.Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alphasynuclein rat model of Parkinson抯 disease[J]. Proc Natl Acad Sci USA, 2004, 101(50):17510-17515. [6] Liu L, Orozco IJ, Planel E, et al.A transgenic rat that develops Alzheimer抯 disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment[J]. Neurobiol Dis, 2008, 31(1):46-57. [7] Cohen RM, Rezai-Zadeh K, Weitz TM, et al.A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a b, and frank neuronal loss[J]. J Neurosci, 2013, 33(15):6245-6256. [8] Pinkert CA.Transgenic Animal Technology: A Laboratory Handbook[M]. Second Edition. Amsterdam: Elsevier Inc, 2004:180-181. [9] Geurts AM, Moreno C.Zinc-finger nucleases: new strategies to target the rat genome[J]. Clin Sci (Lond), 2010, 119(8):303-311. [10] Miller JC, Tan S, Qiao G, et al.A TALE nuclease architecture for efficient genome editing[J] . Nat Biotechnol, 2011, 29(2):143-148. [11] Ann Ran F, Hsu PD, Lin CY, et al.Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing spedificity[J] . Cell, 2013, 154:1380-1389. [12] Pallares P, Garcia-Fernandez RA, Criado LM, et al.Disruption of the endothelial nitric oxide synthase gene affects ovulation, fertilization and early embryo survival in a knockout mouse model.[J]. Reproduction, 2008, 123(5):573-579. [13] Bryant CE, Tomlinson A, Mitchell JA, et al.Nitric oxide synthase in the rat fallopian tube is regulated during the oestrous cycle[J]. J Endocrinol, 1995, 146(1):149-157. [14] Ikeda Y, Aihara K, Yoshida S, et al.Heparin cofactor ii, a serine protease inhibitor, promotes angiogenesis via activation of the amp-activated protein kinase-endothelial nitric-oxidesynthase signaling pathway[J]. J Biol Chem, 2012, 287(41):34256-34263. [15] Teng RJ, Du J, Afolayan AJ, et al.Amp kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 304(1):29-42. [16] Capettini LS, Cortes SF, Lemos VS.Relative contribution of eNOS and nNOS to endothelium-dependent vasodilation in the mouseaorta[J]. Eur J Pharmacol, 2010, 643(2/3):260-266. [17] Stauss HM, Nafz B, Mrowka R, et al.Blood pressure control in eNOS knock-out mice: comparison with other species under NO blockade[J]. Acta Physiol Scand, 2000, 168(1): 155-160. [18] Savard S, Lavoie P, Villeneuve C, et al.eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass[J]. Nephrol Dial Transplant, 2012, 27(6):2182-2190. |